| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +817.2% |
| Cost of Revenue | $363K | +1593.9% |
| Gross Profit | $958K | +681.4% |
| R&D Expense | $511K | +267.6% |
| SG&A Expense | $1.5M | -71.4% |
| Operating Income | -$1.8M | +69.5% |
| Interest Expense | $59K | -27.9% |
| Net Income | -$1.7M | +72.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $163K | -75.4% |
| Short-term Investments | $6.8M | — |
| Accounts Receivable | $5K | -70.1% |
| Inventory | $154K | +391.5% |
| Current Assets | $7.4M | +886.6% |
| Total Assets | $7.4M | +886.1% |
| Current Liabilities | $1.9M | -17.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | -105.8% |
| Investing Cash Flow | -$6.8M | — |
| Financing Cash Flow | $8.5M | +412.7% |
| Total Liabilities |
| $2.0M |
| -19.8% |
| Stockholders' Equity | $5.5M | +425.7% |